Journal of applied clinical medical physics · 2025
Clinical application of cone beam CT in intensity-modulated radiotherapy for the moderate to severe thyroid-associated ophthalmopathy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kang Dan, Hu Hao, Ma Shuyun, Bin Shizhen
Аннотация
BACKGROUND: Cone beam CT (CBCT) has been reported for intensity-modulated radiation therapy (IMRT) of various cancers due to its real-time imaging capabilities, but studies on its application in orbital diseases, particularly moderate to severe thyroid-associated ophthalmopathy (TAO), remain limited.
PURPOSE: To investigate the clinical applications of CBCT in IMRT for TAO, with a focus on setup accuracy, dosimetric impact, and short-term changes in eye prominence.
METHODS: A total of 115 CBCT scans from 17 TAO patients were analyzed. Pretreatment CBCT scans were registered to the planning CT using bony anatomy. The resulting setup errors were quantified in three translational directions. Residual shifts after online correction were tracked to assess interfractional variation and trends throughout the treatment course. Dose-volume histogram from plans recalculated with simulated setup errors (mean and maximum values) were compared to the original plan. Eye prominence was measured on serial CBCT scans, and its correlation with cumulative dose was analyzed.
RESULTS: Mean setup errors were (-0.16 ± 1.09) mm, (-0.19 ± 1.18) mm, and (-0.55 ± 1.05) mm in X, Y, and Z directions. Errors significantly decreased planning target volume (PTV) conformity (p < 0.05) and increased Dmean, Dmax, D2%, and D50% (p < 0.05). For organs at risk (OARs), maximum and mean doses increased, with left lens Dmax increasing by 21.3%, 32.7%, 33.8%, and 13.2% for mean setup errors and X, Y, and Z maximum errors. Right lens showed similar increases. A correlation between CBCT-measured eye prominence and total radiotherapy dose was observed, with the binomial fit: y = 22.43 + 0.12x - (9.94 × 10-3) x2 (R2 = 0.96). Mean eye prominence decreased significantly from (21.74 ± 1.74) mm pre-treatment to (20.94 ± 1.73) mm after 18 Gy of IMRT (p < 0.05).
CONCLUSION: CBCT image guidance for IMRT in moderate to severe TAO improves target conformity and coverage while reducing OAR doses, particularly for lenses. CBCT also shows promise for short-term efficacy assessment of eye prominence in radiotherapy patients which may alleviate patient anxiety with preliminary observation thereby improving patient compliance with radiotherapy.
PURPOSE: To investigate the clinical applications of CBCT in IMRT for TAO, with a focus on setup accuracy, dosimetric impact, and short-term changes in eye prominence.
METHODS: A total of 115 CBCT scans from 17 TAO patients were analyzed. Pretreatment CBCT scans were registered to the planning CT using bony anatomy. The resulting setup errors were quantified in three translational directions. Residual shifts after online correction were tracked to assess interfractional variation and trends throughout the treatment course. Dose-volume histogram from plans recalculated with simulated setup errors (mean and maximum values) were compared to the original plan. Eye prominence was measured on serial CBCT scans, and its correlation with cumulative dose was analyzed.
RESULTS: Mean setup errors were (-0.16 ± 1.09) mm, (-0.19 ± 1.18) mm, and (-0.55 ± 1.05) mm in X, Y, and Z directions. Errors significantly decreased planning target volume (PTV) conformity (p < 0.05) and increased Dmean, Dmax, D2%, and D50% (p < 0.05). For organs at risk (OARs), maximum and mean doses increased, with left lens Dmax increasing by 21.3%, 32.7%, 33.8%, and 13.2% for mean setup errors and X, Y, and Z maximum errors. Right lens showed similar increases. A correlation between CBCT-measured eye prominence and total radiotherapy dose was observed, with the binomial fit: y = 22.43 + 0.12x - (9.94 × 10-3) x2 (R2 = 0.96). Mean eye prominence decreased significantly from (21.74 ± 1.74) mm pre-treatment to (20.94 ± 1.73) mm after 18 Gy of IMRT (p < 0.05).
CONCLUSION: CBCT image guidance for IMRT in moderate to severe TAO improves target conformity and coverage while reducing OAR doses, particularly for lenses. CBCT also shows promise for short-term efficacy assessment of eye prominence in radiotherapy patients which may alleviate patient anxiety with preliminary observation thereby improving patient compliance with radiotherapy.